redditalpha logoredditalpha
← Back to dashboard
Share
Reddit ticker intel

LLY

Health Care
Eli Lilly
No Reddit discussion for this ticker in the last 24h.
Community thesis
· Distilled from real DD posts; click ↗ for the source

Bulls ⚔ Bears · how Reddit is debating it

Bull case

0 stances
  • Injectable GLP-1 product is considered superior to NVO's offering.
  • Passes the Value Score threshold of 2.0, highlighting a compelling mix of profitability and growth.
  • Included in the current portfolio, signaling confidence in its current valuation.
  • Selected by author's proprietary Value Score model (>2.0), indicating strong undervaluation relative to growth and margins.
  • Included in the author's core portfolio that has achieved a 65.8% YTD return.
  • Poised to capture the next leg of the GLP-1 trade with oral formulations like orforglipron.

Bear case

0 stances
  • Novo's promising pipeline candidates like UBT251 could take meaningful market share and challenge Eli Lilly's current dominance in obesity treatments.
  • Novo's promising pipeline candidates, such as UBT251, are expected to capture meaningful market share and challenge Eli Lilly's current dominance in obesity treatments.
  • The post relies heavily on hype ('rocket fuel', 'ignite') rather than detailed financial valuation or risk analysis.
  • Market expectations may already be priced in given the anticipation mentioned ('bought a ton of their stock').
  • Single-day price action is statistically insignificant and prone to noise rather than signaling a trend.
  • Resilience may reflect temporary capital rotation rather than sustainable long-term value appreciation.

Credible voices

Discussing this ticker · by content quality
u/One_Big2047
1 posts · 5 upvotes
0.85
+0.80
u/Hungry_Confection108
2 posts · 2 upvotes
0.80
+0.80
u/Constant-Bridge3690
2 posts · 65 upvotes
0.72
+0.78
u/No-Fig-8614
1 posts · 160 upvotes
0.60
+0.85
u/Savings_Industry_405
2 posts · 3 upvotes
0.60
0.00
u/Far-East-locker
1 posts · 5 upvotes
0.30
+0.60

Catalysts · themes

What the community is watching
GLP-1 减肥药 · 9价值 / 回购 · 5AI 资本开支 · 1半导体 · 1

Community split

Which subreddits the mentions come from
r/valueinvesting
6
r/investing
2
r/wallstreetbets
1
r/stocks
1
r/stockmarket
1

Related narratives

High-quality DD posts

11 total
1
r/wallstreetbetsr/wallstreetbets· u/Hungry_Confection108· 1d agoDD
NOVO NORDISK is a great play now

Novo Nordisk's recent price cuts will solidify its market dominance, deter competitors, and unlock massive growth in Europe and its pipeline.

0Bullish★ High signalNVOLLYGLP-1 减肥药
1
r/valueinvestingr/valueinvesting· u/Hungry_Confection108· 1d agoDetailed Investment Analysis
NOVO is a great play at this price

Novo Nordisk's price cuts will deter competitors, while European expansion and a promising pipeline challenge Eli Lilly's dominance.

1Bullish★ High signalNVOLLYGLP-1 减肥药价值 / 回购
1
r/valueinvestingr/valueinvesting· u/GWillHunting· 5d agoStock Analysis
What’s with NVO’s management - up 1.25% in 5 years

Author is furious about NVO's poor stock performance despite GLP-1 leadership, blaming terrible management or fraud.

0BearishNVOLLYGLP-1 减肥药
1
r/investingr/investing· u/Plead_thy_fifth· 5d ago
I am officially taking my personal company public! Time to IPO and go from investing to invested in!!... (Hot take)

The author jokingly values his side hustle using P/E ratios of TSLA, AVGO, LLY, and MA, sarcastically offering shares to Reddit users.

0NeutralTSLAAVGOLLY
0
r/investingr/investing· u/Constant-Bridge3690· 6d ago
My value picks for the rest of the year

Author shares a value model based on growth, margins, and EV multiples, holding MU, NVDA, GOOGL, LLY, MSFT, META with 65.8% YTD returns.

12Bullish★ High signalMUNVDAGOOGLLLYMSFTAI 资本开支GLP-1 减肥药
65
r/valueinvestingr/valueinvesting· u/Constant-Bridge3690· 6d agoDiscussion
My value picks for the rest of the year

Author shares a value model based on growth, margins, and EV multiple, holding MU, NVDA, GOOGL, LLY, MSFT, META with 65.8% YTD return.

114Bullish★ High signalNVDAGOOGLMSFTMETALLY价值 / 回购
5
r/valueinvestingr/valueinvesting· u/One_Big2047· 6d agoDiscussion
Biotech is the next big thing

Big pharma's patent cliff drives aggressive M&A, creating a floor for small-cap biotech, while GLP-1 oral versions offer new growth.

9Bullish★ High signalPFELLYNVOGLP-1 减肥药价值 / 回购
160
r/stocksr/stocks· u/No-Fig-8614· 7d agoCompany News
Eli Lilly is ready to soar with their latest results get ready for Triple Action GLP's

Bullish on LLY due to promising Phase 3 results for Retatrutide, claiming superiority over Novo's pipeline and expanded indications.

74BullishLLYGLP-1 减肥药
3
r/valueinvestingr/valueinvesting· u/Savings_Industry_405· 7d agoDiscussion
Aggressive Roth IRA at 18 — What Would You Change?

An 18yo seeks advice on an aggressive Roth IRA portfolio, questioning tech concentration and international exposure.

3NeutralVOOMETAGOOGLLLYVTIGLP-1 减肥药价值 / 回购
0
r/stockmarketr/stockmarket· u/Savings_Industry_405· 7d agoDiscussion
Aggressive Roth IRA at 18 – What Would You Change?

18yo asks for feedback on an aggressive Roth IRA portfolio heavily weighted towards US tech and large-cap ETFs.

29NeutralVOOMETAGOOGLLLYVTIGLP-1 减肥药
5
r/valueinvestingr/valueinvesting· u/Far-East-locker· 7d agoDiscussion
On a day like 5/6, if a stock stays flat or even closes green, does that mean something?

User questions if LLY's resilience during a broad market sell-off indicates strong bullish momentum and a buy signal.

9BullishLLYGLP-1 减肥药